- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 281/18 - Compounds containing any of the groups e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
Patent holdings for IPC class C07C 281/18
Total number of patents in this class: 80
10-year publication summary
15
|
7
|
6
|
7
|
10
|
2
|
6
|
0
|
2
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
United Kingdom Research and Innovation | 362 |
12 |
Neoculi Pty Ltd | 18 |
10 |
Inflectis Bioscience | 16 |
6 |
Guangzhou Insighter Biotechnology Co., Ltd. | 51 |
5 |
The United States of America, as represented by the Secretary of Agriculture | 1044 |
4 |
Ferring B.V. | 713 |
3 |
Medical Research Council | 160 |
3 |
Mitsubishi Gas Chemical Company, Inc. | 3351 |
3 |
Ospedale San Raffaele S.r.l. | 260 |
3 |
UT-Battelle, LLC | 1394 |
3 |
Ferring B.V. | 7 |
2 |
Lantheus Medical Imaging, Inc. | 174 |
2 |
Method Products, PBC | 126 |
2 |
Regents of the University of Minnesota | 2684 |
2 |
University of Kentucky Research Foundation | 685 |
2 |
Inspirna, Inc. | 38 |
2 |
Methods Products, PBC | 3 |
2 |
The Regents of the University of California | 19572 |
1 |
JPMorgan Chase Bank, National Association | 8427 |
1 |
Acure Pharma AB | 4 |
1 |
Other owners | 11 |